Regulation of skeletal muscle development requires many of the regulatory networks that are fundamental to developmental myogenesis. ErbB3 binding protein-1 (Ebp1) is involved in the control of myoblasts development in chicken. However, the expression and biological functions of Ebp1 in the progress of myogenesis are unclear. This study focused on determining the effect of Ebp1 on myogenic proliferation and differentiation using a primary myoblasts culture model. Ebp1 was found to upregulate in proliferating myoblasts and decrease at the early stage of myogenic differentiation. The level of endogenous Ebp1 increased from E9 to E20 chicken leg muscles. Knockdown of Ebp1 had no effect on myoblasts proliferation. However, myogenic differentiation into multinucleated myotubes was significantly reduced. The mRNA and protein expression of MRFs was decreased when Ebp1 was knocked down. Downregulation of Ebp1, accompanied by elevated levels of pSMAD2/3, suggests that Ebp1 is involved in regulating myogenic differentiation via SMAD2/3 inhibition. The phosphorylation of SMAD2/3 was activated and the expression of MYOD and MYOG was reduced in Ebp1 knockdown myoblasts, but addition of LY2109761 (an inhibitor specified to SMAD2/3) blocked these effects. Collectively, these results indicate that Ebp1 promotes myoblast differentiation by inhibition of SMAD2/3 signaling pathway during chicken myogenesis. These data provide new insights into the biological role of Ebp1 in embryonic chicken skeletal muscle development.
Introduction
The formation of skeletal muscle involves a series of complicated steps. Paraxial mesodermal cells first commit to the mononucleated myoblasts lineages (Abmayr & Pavlath 2012) . Myoblasts then halt the cell cycle and fuse to form multinucleated myotubes (Abmayr & Pavlath 2012; Hochreiter-Hufford et al. 2013) . When myogenesis begins, the expression of Pax3/7 gradually decreases (Relaix et al. 2005) , and the expression of muscle-regulatory factors (MRFs), including MyoD, Myf5, myogenin (MyoG) and Mrf4, increases greatly (Kassar-Duchossoy et al. 2004; Kim et al. 2009 ). Myoblasts fused with each other to form skeletal muscle fibers in terminal differentiation (Berkes & Tapscott 2005; Yokoyama & Asahara 2011) . The balance between myoblast proliferation and differentiation is important during muscle development (Yokoyama & Asahara 2011) .
EBP1 belongs to the PA2G4 family of transcription factors, which appears to fulfill multiple diverse biological functions (Pisapia et al. 2015; Hwang et al. 2016; Ko et al. 2016) . EBP1 has active involvement of cell growth, apoptosis and differentiation in many cell types (Radomski & Jost 1995; Xia et al. 2001; Ko et al. 2015) . Ebp1 is well-conserved, which expressed in satellite cells and C2C12 myoblasts in mouse (Figeac et al. 2014) . Recent studies have shown that Ebp1 is weakly expressed in mouse skeletal muscles and is highly expressed in muscle progenitors and adult muscle stem cells but not in quiescent satellite cells (Xia et al. 2001; Figeac et al. 2014) . Ebp1 was strongly induced during myoblast activation, remaining at high levels during proliferation and differentiation. Previous studies have shown that EBP1 plays a crucial role in the growth of many cancer cells by interacting with other proteins (Zhou et al. 2011; Miao et al. 2015; Zhang et al. 2015) . However, the molecular mechanisms of Ebp1 on the development of myoblasts are unclear.
The molecular mechanisms underlying myoblasts development involves interaction with multiple signaling pathways. In our previous study, results showed that activation of PI3K/Akt signaling pathway by IGF-1 exerted important roles in promoting myoblasts proliferation and inducing skeletal muscle growth in chicken . TGF-b signaling components exert physiological control over proliferation, differentiation, apoptosis, adhesion and extracellular matrix deposition, thereby controlling embryogenesis, organogenesis and adult tissue homeostasis (Zhu et al. 2004; Yokoyama & Asahara 2011; Egerman & Glass 2014) . It has been shown that TGF-b superfamily block muscle differentiation (Trendelenburg et al. 2009 ). Previous research has also suggested that knockdown of SMAD2/3 by siRNA was shown to induce differentiation (Sartori et al. 2009 ).
It is currently unclear which signaling pathway is responsible for the regulation of myogenesis by Ebp1 and, as such, further studies are required to determine the molecular mechanisms of Ebp1 in skeletal muscle development. In the present study, it was explored how Ebp1 regulates the expression of MRFs and MyHC, and demonstrated the functional importance of Ebp1 in modulating myogenic differentiation by using Ebp1 knockdown myoblasts cell model. This study offers insights into the biological function and mechanism of Ebp1 in myoblasts differentiation.
Material and methods

Culture of embryonic chicken myoblasts
All animal experiments were approved by the Animal Care and Use Committee of Nanjing Agricultural University. Fertilized SASSO chicken (Gallus gallus) eggs were incubated in an egg incubator (GRUM-BACH BSS160, Germany) at 38.5°C and 60% humidity. Myoblasts were isolated and purified using a differential attachment technique as previously described . In brief, the muscle samples were first rinsed in PBS, then minced into small tissue pieces of one mm 3 and digested in 0.25% trypsin in Dulbecco's Modified Eagle Medium (DMEM) for 3-5 min at 37°C. Myoblasts were then expanded in number for up to another 48 h. To enhance proliferation, myoblasts were cultured in high-serum medium. Growth medium (GM) was composed of DMEM with 15% FBS, and 1% penicillin-streptomycin. The cells were maintained in an incubator with 5% CO 2 at 37°C. The culture medium was changed every other day, and cells were passaged until approximately 80% confluence was attained. Differentiation was initiated 72 h after seeding by changing to differentiation medium (DM) consisting of DMEM supplemented with 2% horse serum (Gibco, Carlsbad, CA, USA), 1% penicillin-streptomycin, and 1% glutamine.
RNA extraction and qPCR analysis
Total RNA was extracted from cultured myoblasts or skeletal muscles using TRIzol reagent (Invitrogen, Carlsbad, CA, USA). The PrimeScript RT Master Mix (TaKaRa, Dalian, China) was used to synthesize cDNA. Real-time PCR analysis was conducted using a StepOne plus Real-Time PCR System (Applied Biosystems) with SYBR Premix ExTaq II (Takara, Dalian, China). Primers are shown in Table 1 . Each sample was repeated in triplicate and the fold change in gene expression was calculated according to the 2
Ebp1 knockdown
Lentiviral constructs for shRNA were designed by GenePharma (GenePharma Co., Ltd, Shanghai, China). The sequences of shRNA are listed in Table 2 . Myoblasts were re-plated at 1.5 9 10 5 cells per well in six well dishes. Myoblasts were maintained in high-serum GM for 24 h before medium replacement and infected with LV-shEbp1 or negative control for overnight. After selection of puromycin (10 lg/mL), transfected myoblasts were induced differentiation in DM, and then myoblasts differentiation was analyzed by qRT-PCR and western blot.
Immunofluorescence staining
Cultured myoblasts were fixed in 4% paraformaldehyde, blocked with TBS (containing 5% goat serum and 0.1% Triton X-100) for 30 min, and incubated with mouse anti-MyHC primary antibody (1:500; Abcam, Cambridge, UK) overnight at 4°C. After incubated with TRITC-conjugated secondary antibody (1:500, KPL Inc., Maryland, USA) for 1 h, nuclei were counterstained with 4 0 -6-diaminidino-2-phenylindole (DAPI). Cells were analyzed immediately after staining using a confocal laser microscope (Zeiss LSM 700; Carl Zeiss AG, Germany).
Western blot
Myoblasts was lysed in RIPA buffer supplemented with protease inhibitors (Complete; Roche) and 0.2 nmol/L GMSF. Proteins were denatured and ª 2017 Japanese Society of Developmental Biologists subjected to 10% polyacrylamide gel and transferred to methanol-activated PVDF membranes. Blots was probed using the primary antibodies: mouse anti-EBP1, rabbit anti-MFY5, mouse anti-PAX7, mouse anti-MYOD, mouse anti-MYOG, mouse anti-MHC (1:500; Abcam), and rabbit anti-SMAD2 phosphoS467, rabbit anti-SMAD3 phosphoS423 + S425, rabbit anti-SMAD2 or rabbit anti-SMAD3 (1:1000; Abcam) and b-Actin antibody (1:5000, Novus Biologicals, USA) overnight at 4°C. After 1 h incubation with anti-mouse or anti-rabbit HRP-conjugated second antibody (1:5000, Cell Signaling, Beverly, MA, USA), blots were developed by enhanced chemiluminescence (Amersham, USA). The density of the protein bands was analyzed using Image J software (US National Institutes of Health).
EdU (5-ethynyl-2
0 -deoxyuridine) proliferation assay
After transfection and selection, EdU reagents (RIBOBIO, Guangzhou, China) (final concentration, 10 mmol/L) were added for 4 h before fixation, permeabilization, and EdU staining (Click-iT EdU Imaging Kit, Life technologies). EdU is a nucleoside analog of thymidine that is incorporated into DNA during active DNA synthesis only by proliferating cells. Nuclei were stained with 4´6´-diamidino-2-phenylindole dihydrochloride (DAPI) (5 lg/mL) for 30 min. The proportion of EdU-positive cells were detected by fluorescence inverse microscope (five random fields were captured for each treatment group, n = 5).
Flow cytometric analysis
Flow cytometric analysis (FACS) was performed as previously described (Yu et al. 2011) . Briefly, myoblasts were fixed with 70% ethanol at À20°C for 30 min after washing with ice-cold PBS. The cells were incubated with staining solution (50 lg/mL propidium iodide, 0.1% Triton X, and 100 lg/mL RNase A in PBS) for 15 min in the dark. The stained cells were analyzed by flow cytometry (BD FACS CELLU-LAR). A minimum of 15 000 cells were analyzed for each sample. The assay was repeated three times.
Statistical analysis
All experiments were conducted on three independent samples. All data were presented as the means AE SE, and statistical evaluation of the data was conducted with SPSS 18.0. The statistical analysis was performed with an unpaired Student's t-test to compare two groups. Differences at P < 0.05 were considered to statistical significance. 
Results
Morphological and biochemical differentiation of myoblasts
Myoblasts isolated from the E9 chicken leg muscle was cultured in GM to proliferate, and induced to differentiate in low-serum DM. The number of myoblasts in GM was significantly increased and maintained the mononucleate morphology (Fig. 1A) . After being cultured in DM for 1 day, myoblasts exhibited reduced morphology and increased differentiation and began to fuse into multinucleated myotubes (Fig. 1A) . After 2 days of induction, the number of myotubes was significantly increased and nucleus fused together and showed elongated morphology (Fig. 1A) . The majority of myoblasts were fused to form multinucleate myotubes by 3 days of culture in DM (Fig. 1A) . The ratio of muotubes increased from D1 to D3, and the multinucleate matured myotubes were formed since D2. During these processes, the expression of transcription factors Pax7 and Myf5 dramatically decreased (Fig. 1B) . MyoD was highly expressed in late-stage proliferating myoblasts and remained so at the initiation of myogenic differentiation, followed by a sharp decline (Fig. 1B) . Conversely, MyoG, Desmin and Mrf4, myogenic factors which are all associated with differentiation and myotube maturation, were all gradually upregulated (Fig. 1B) .
Ebp1 is upregulated during myogenic differentiation
Endogenous Ebp1 expression was measured in E9-E20 skeletal muscles of embryonic chickens. The level of Ebp1 was continually increased following the development of skeletal muscles in chicken embryos ( Fig. 2A) . Ebp1 expression was then measured in cultured myoblasts during proliferation and commitment to differentiation. RNA was extracted from myoblasts cultured in GM/DM for 1-3 days, and Ebp1 expression was assessed in parallel with MyHC. The result showed that the proliferating myoblast cells expressed robust amounts of Ebp1, and the expression level increased from D1 to D3 in DM (Fig. 2B) . Although Ebp1 expression remained increase in DM, the levels of Ebp1 decreased as cells initiated differentiation, and then increase significantly in D2 and D3 (Fig. 2B) . Expression of MyHC mRNA was increased following the culture (Fig. 2B ).
To determine whether EBP1 protein expression followed the dynamics of gene expression, the protein expression of EBP1 and MyHC was detected in proliferating and differentiating myoblasts. EBP1 protein was expressed in both proliferating and differentiating myoblasts (Fig. 2C-D) . The level of EBP1 expression was increased gradually in GM and remained at a high level in DM (Fig. 2C-D) . The expression of EBP1 decreased in D1 compared to P3, while the highest level was in D2 and there is no significant difference in D2 and D3 (Fig 2C-D) . The protein expression of MyHC (a marker of terminal differentiation in myotubes) was obviously increased in DM (Fig. 2C-D) .
The preparation of Ebp1 knockdown myoblasts
To investigate the effect of Ebp1 on myoblasts development, four pairs of shRNA specific to Ebp1 were designed to reduce its function (Fig. 3A) . Among the four shRNAs, LV2 produced the best reducing effect Ebp1 promotes myoblasts differentiationon Ebp1 expression. As a result, the Ebp1 mRNA level was 80% lower than the control after transfection (Fig. 3B) . Results showed that the fluorescent expression was first detected in very few myoblast cells at 24 h. Then positive cells were increased gradually and were widespread at 96 h (Fig. 3C) . Puromycin (0-10 lg/mL) was used to select positive cells, which was transfected successfully. The fluorescence expression ª 2017 Japanese Society of Developmental Biologists showed 8 or 10 lg/mL puromycin was the optimal concentration ( Fig. 3D) . After transfection and selection, the high purified Ebp1 knockdown myoblasts was used for induction of myoblasts differentiation.
Ebp1 knockdown has no effect on myoblasts proliferation
To address the effect of Ebp1 on myoblasts proliferation, EdU incorporation assay, cell cycle regulating genes expression and flow cytometry analysis were performed in transfected myoblasts cultured in GM for 72 h (Fig. 4) . The result of EdU incorporation indicated that there was no obvious change of proliferating cell number in LV-shEbp1 treated myoblasts compared with control ( Fig. 4A-C) . The expression of CyclinD1 and c-Myc was no significant difference after knockdown of Ebp1 (P > 0.05) (Fig. 4D ). These data were further supported by FACS, which is widely used to assess cell proliferation. G1-phase was 70.67% AE 0.66 and 69.35% AE 1.02 (P > 0.05) in NC and LV-shEbp1, respectively (Fig. 4E-F) . This result confirmed that there was no significant difference in cell cycle. These results suggest that Ebp1 exerts no influence on myoblasts proliferation.
Ebp1 knockdown inhibits myoblasts differentiation
To evaluate the potential involvement of Ebp1 on myoblasts differentiation, the expression of MRFs was detected in myoblasts treated with LV-shEbp1 for 1 and 2 days. Knockdown of Ebp1 significantly reduced myoblast differentiation (Fig. 5) . The mRNA levels of Myf5, MyoD, MyoG and Mrf4, but not Desmin or Mef2a, were significantly reduced in myoblasts treated with LV-shEbp1 for 1 days (Fig. 5A) . Protein levels of MYOD and MYOG were significantly reduced as well. However, the protein level of MYF5 had no obvious change (Fig. 5B-C) . Expression of PAX7 and MyHC was also decreased in LV-shEbp1-treated myoblasts (Fig. 5B-C) . In DM for 2 days, the level of Ebp1 was also significantly lower than that of the control (Fig. 5D) , and the RNA and protein level of myogenic factors showed significant decreases ( Fig. 5D-F) . The protein expression of MYOD, MYOG and MyHC were also decreased in Ebp1 knockdown cells (Fig. 5E-F) . These results indicate that Ebp1 knockdown attenuates myogenic differentiation.
To confirm the effect of Ebp1 knockdown on myoblasts differentiation, the morphology of myoblasts was assessed. Ebp1 knockdown myoblasts exhibited Ebp1 promotes myoblasts differentiationmarkedly reduced differentiation at 2 days in DM compared with the control (Fig. 5G) . Under this condition, myoblasts maintained their reduced differentiation, and had showed small, mononuclear fibroblast-like morphology in the presence of LV-shEbp1, whereas myoblasts cultivated in NC-shRNA clearly exhibited elongated, multi-nucleated myotube formation (Fig. 5G) . These morphological findings were supported biochemically with immunostaining of the differentiation marker-MyHC (Fig. 5G-H) . The fusion index decreased significantly in myoblasts treated with LVshEbp1 for 2 days (22.17 AE 3.4 vs. 11.88 AE 2.84, P < 0.005) when compared with control ( Fig. 5G-H) .
Knockdown of Ebp1 prevented the formation of myotubes. These results suggest that the shRNA-mediated knockdown of Ebp1 in myoblasts leads to defective differentiation and fusion.
Ebp1 inhibits myoblasts differentiation by SMAD2/3 inhibition
To determine which signaling pathways may be function downstream of Ebp1 to induce differentiation, western blots were performed following incubation with Ebp1 knocked down myoblasts in DM for 2 days. The expression of pSMAD2/3 increased (2.35-fold and ª 2017 Japanese Society of Developmental Biologists 1.44-fold, respectively) in myoblasts treated with LVshEbp1 compared with the control (Fig. 6A-B) . LY2109761, an inhibitor specific to SMADs, was used to test the role of SMAD2/3 in myoblasts differentiation. Inhibition appeared to occur as a consequence of inactive SMAD2/3 phosphorylation, increased MYOD and MYOG expression and ultimately promoted differentiation of myoblasts (Fig. 6C-D) . Then the proteins expression of MRFs and SMAD2/3 were detected by treatment of shEbp1 and/or LY2109761 (Fig. 6E-F) .
Results suggested that pSMAD2/3 was upregulated and MYOD/MYOG was downregulated when Ebp1 was knocked down. While these effects induced by LV-shEbp1 was blocked by addition of inhibitor. When treated with LV-shEbp1 and LY2109761 together, the MYOD/MYOG expression level was similar to control. These data demonstrate that Ebp1 induce the expression of MRFs by suppressing phosphorylation of SMAD2/3. Collectively, these results suggest a model demonstrating the biological role of Ebp1 in myogenesis (Fig. 6G) . In the proposed model, Ebp1 inhibits TGFb/ SMAD2/3 signaling pathway, while inactivation of SMAD2/3 enhances MRFs and MyHC expression which leading to terminal differentiation of myoblasts. Taken together, Ebp1 appears to be involved in increasing MRFs expression in response to the inhibition of SMAD2/3 signaling pathway. and MyHC were analyzed using western blot. After cultured in DM for 2 days, the mRNA (D) and protein (E-F) of Ebp1 and myogenic genes were analyzed. (G) The expression of MyHC (red) in myoblasts in DM for 2 days post-transfection was detected using immunofluorescence. The nuclei were counterstained with DAPI (blue). (H) The number of MyHC-positive myotubes was calculated. Scale bar: 100 lm. NC: native control; shRNA Ebp1: knockdown site LV2. Data are presented as the means AE SE. P < 0.05 is shown as *, P < 0.01 is shown as **.
ª 2017 Japanese Society of Developmental Biologists the mechanism responsible for Ebp1 function in myoblasts still needs to be elucidated. Further studies are required to determine the specific role and physiological importance of Ebp1 in skeletal muscle. The aim of this study is to clarify the potential molecular mechanism of Ebp1 in myogenesis and to gain insights into its biological function in myoblasts development in chicken.
The biological effects of EBP1 vary depending on cell type and context, although the precise mechanisms for the differential roles and regulation of EBP1 in different tissues have not been defined (Miao et al. 2015; Pisapia et al. 2015; Hwang et al. 2016) . Previous study showed that Ebp1 is weakly expressed in mouse skeletal muscles, and its expression is higher in activated versus quiescent satellite cells (Squatrito et al. 2004; Pallafacchina et al. 2010; Figeac et al. 2014) . Since Ebp1 expression is well-conserved, it plays a vital role in chicken muscle formation. Ebp1 was expressed in a dynamic fashion during myogenic progression in chicken. The expression of Ebp1 increases gradually in skeletal muscles during developmental myogenesis, it especially upregulates remarkably since E15 in which stage myoblasts commit differentiation in vivo. Ebp1 was found at high levels in the process of myoblast proliferation and differentiation in vitro. Moreover, Ebp1 decreased when GM was replaced with DM, while it increased significantly in the following differentiation stages. This implicates that Ebp1 exerts critical influence on the initiation of myogenic differentiation.
In many cancer cells, Ebp1 regulates cell proliferation and survival . Ebp1 increases at the G1/S boundary, and greatly reduced during S phase or in quiescent cells (Judah et al. 2010) . Ebp1 knockdown inhibited both proliferation and differentiation of Ebp1 promotes myoblasts differentiationsatellite cells and C2C12 myoblasts in mouse (Figeac et al. 2014) . In contrast, although Cyclin D1 and c-Myc expression levels did increase slightly, knockdown of Ebp1 did not significantly influence the cell cycle in chicken. The findings were further supported by EdU incorporation and FACS. Taken together, the results indicate that Ebp1 has no significant effect on myoblasts proliferation in chicken.
However, myogenic differentiation into multinucleated myotubes was significantly reduced in Ebp1 knockdown myoblasts. The potential mechanisms underlying the positive impact of Ebp1 on myoblasts differentiation was characterized. MRFs are important factors that directly regulate the myogenesis (Kim et al. 2009 ). Ebp1 promoted MRFs expression and subsequently myogenic differentiation of myoblasts (Figeac et al. 2014) Myf5 and MyoD are direct up-stream targets of MyoG in the muscle gene network, and they induce cell differentiation (Myer et al. 2001; Yokoyama & Asahara 2011) . This study showed that the expression of MyoD was highest in the process of terminal myoblast proliferation (P3), while Myf5 was decreased significantly in DM. Expression of MyoG and Mrf4 increased in terminal myoblasts differentiation (D2-D3). It showed that Ebp1 was a positive regulator of myogenesis and increased during myogenic differentiation. The expression of MRFs in Ebp1 knockdown myoblasts was significantly reduced. Furthermore, knockdown of Ebp1 inhibited the expression of MyHC and Pax3. Similarly, immunostaining showed that the number of myotubes decreased significantly. These results indicate that Ebp1 stimulates myoblasts differentiation by promoting the expression of MRFs and MyHC. This observation is in contrast to a previous study, which showed that knockdown of Ebp1 only inhibits the mRNA expression of MyoG (Myer et al. 2001) . Another study found that c-Myc inhibited the MyoD and MyoG-initiated myogenic differentiation (Miner & Wold 1991) . In our study, the expression of c-Myc in myoblast cells was not influenced by Ebp1 knockdown, while the expression of MyoD and MyoG was decreased greatly. These data suggest that Ebp1 is involved in regulating myoblasts differentiation by regulating MRFs, without influencing cell cycle. However MRFs are targets of various signaling pathways, which is responsible for the regulation of myoblasts differentiation by Ebp1 is unknown.
Multiple signaling pathways regulate the dynamic balance of skeletal muscle development. The AKT/mTOR pathway controls protein synthesis and IGF1 pathway promotes myoblasts expansion and muscle fiber formation (Trendelenburg et al. 2009; Yu et al. 2015) . The Smad2/3 and AKT signaling pathways induce differentiation (Trendelenburg et al. 2009; Egerman & Glass 2014) . Another study showed that MSTN suppresses MYOG through SMAD2/3 signal pathway modulation in the process of myoblast differentiation (Zhu et al. 2004) . To determine which signaling pathways may be functioning downstream of Ebp1 to active differentiation, myoblasts were treated with LV-shEbp1 and/or LY2109761. The elevated pSMAD2/3 in the myoblasts treated with LV-shEbp1 was found. The levels of MYOG and MYOD were noticeably increased in myoblasts treated with a SMAD2/3 inhibitor. These data show that Ebp1 contributes to myoblasts differentiation by inhibition of SMAD2/3 pathway and upregulation of MRFs expression.
Conclusion
The results showed that Ebp1 plays no obvious role of myoblasts proliferation, but has remarkable regulatory effects on myoblasts differentiation in chicken. Knockdown of Ebp1 significantly activates the phosphorylation of SMAD2 and SMAD3, reduces the expression levels of MRFs and MyHC, and then inhibits myoblasts differentiation. These findings showed a novel regulatory role and physiological importance of Ebp1 on myogenic development by inactivating SMAD2/3 signaling pathway. The present study has further defined molecular mechanisms leading to myogenesis, especially the signaling pathway that induces myogenic differentiation, which is also essential for skeletal muscle development.
